Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 19875954)

1.

Is the expression pattern of BD ProExC the same as Ki-67? A comparative analysis in cervical biopsies.

Walts AE, Bose S.

Appl Immunohistochem Mol Morphol. 2010 May;18(3):262-7. doi: 10.1097/PAI.0b013e3181c1f99f.

PMID:
19875954
2.

BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.

Badr RE, Walts AE, Chung F, Bose S.

Am J Surg Pathol. 2008 Jun;32(6):899-906. doi: 10.1097/PAS.0b013e31815bbb69.

PMID:
18425044
3.

[Expression of ProEXC, p16 and Ki-67 in cervical intraepithelial lesion by immunohistochemistry: diagnostic and clinical significance].

Yang QC, Liu HB, Zhu Y, Zhang XJ, Shen Y, Ji XH.

Zhonghua Bing Li Xue Za Zhi. 2012 Jun;41(6):405-7. doi: 10.3760/cma.j.issn.0529-5807.2012.06.010. Chinese. No abstract available.

PMID:
22932410
4.

p16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia.

Walts AE, Bose S.

Hum Pathol. 2009 Jul;40(7):957-64. doi: 10.1016/j.humpath.2008.12.005. Epub 2009 Mar 9.

PMID:
19269017
5.

Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection.

Mimica M, Tomić S, Kardum G, Hofman ID, Kaliterna V, Pejković L.

Int J Gynecol Cancer. 2010 Jan;20(1):116-9. doi: 10.1111/IGC.0b013e3181bc8da7.

PMID:
20130511
6.

p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.

Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B.

Pathology. 2005 Apr;37(2):112-24.

PMID:
16028838
7.

[Association of p16, p53, Ki-67 expressions with high-risk human papilloma virus infection in cervical intraepithelial neoplasia].

Shi J, Zheng JS, Yin F, Hu WW, Huang XJ, Zhou XL.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Apr;27(4):515-7. Chinese.

8.

Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens.

Sanati S, Huettner P, Ylagan LR.

Int J Gynecol Pathol. 2010 Jan;29(1):79-87. doi: 10.1097/PGP.0b013e3181ae81a0.

PMID:
19952938
9.

The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins.

Song SH, Park HM, Eom DW, Lee JK, Lee NW, Kim AR, Hur JY, Lee KW, Park YK, Saw HS.

Int J Gynecol Cancer. 2007 Jul-Aug;17(4):858-67. Epub 2007 Mar 15.

PMID:
17367326
10.

Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.

Wang WC, Wu TT, Chandan VS, Lohse CM, Zhang L.

Hum Pathol. 2011 Oct;42(10):1430-7. doi: 10.1016/j.humpath.2010.12.009. Epub 2011 Mar 21.

PMID:
21420715
11.

Histology of cervical intraepithelial neoplasia and the role of biomarkers.

Martin CM, O'Leary JJ.

Best Pract Res Clin Obstet Gynaecol. 2011 Oct;25(5):605-15. doi: 10.1016/j.bpobgyn.2011.04.005. Epub 2011 Jun 1. Review.

PMID:
21636328
12.

Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma.

Guo M, Baruch AC, Silva EG, Jan YJ, Lin E, Sneige N, Deavers MT.

Am J Clin Pathol. 2011 Feb;135(2):212-20. doi: 10.1309/AJCP1LLX8QMDXHHO.

13.

Comparison of topoisomerase II alpha and MIB-1 expression in uterine cervical squamous lesions.

Gibbons D, Fogt F, Kasznica J, Holden J, Nikulasson S.

Mod Pathol. 1997 May;10(5):409-13.

PMID:
9160303
14.
15.

Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading.

Kruse AJ, Baak JP, de Bruin PC, Jiwa M, Snijders WP, Boodt PJ, Fons G, Houben PW, The HS.

J Pathol. 2001 Jan;193(1):48-54.

PMID:
11169515
16.

Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.

Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.

Coll Antropol. 2010 Mar;34(1):19-24.

PMID:
20432728
17.

Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions.

Saha B, Chaiwun B, Tsao-Wei DD, Groshen SL, Naritoku WY, Atkinson RD, Taylor CR, Imam SA.

Int J Gynecol Pathol. 2007 Jul;26(3):214-22.

PMID:
17581401
18.

In vivo cyclin E expression as a marker for early cervical neoplasia.

Quade BJ, Park JJ, Crum CP, Sun D, Dutta A.

Mod Pathol. 1998 Dec;11(12):1238-46.

PMID:
9872657
19.

Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?

Lorenzato M, Caudroy S, Bronner C, Evrard G, Simon M, Durlach A, Birembaut P, Clavel C.

Hum Pathol. 2005 Oct;36(10):1101-7.

PMID:
16226110
20.

Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study.

Conesa-Zamora P, Doménech-Peris A, Orantes-Casado FJ, Ortiz-Reina S, Sahuquillo-Frías L, Acosta-Ortega J, García-Solano J, Pérez-Guillermo M.

Am J Clin Pathol. 2009 Sep;132(3):378-90. doi: 10.1309/AJCPO0WY1VIFCYDC.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk